advertisement
Trost A 23
Showing records 1 to 23 | Display all abstracts from Trost A98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Bippes CC
Molecular Therapy 2022; 30: 855-867
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Strempfl K
Biomolecules 2022; 12:
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Mayr D
Current Eye Research 2022; 0: 1-7
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Unger MS
Biomolecules 2022; 12:
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Kohler C
Molecular Therapy 2022; 30: 855-867
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Preishuber-Pflügl J
Current Eye Research 2022; 0: 1-7
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Flunkert S
Biomolecules 2022; 12:
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Garcia-Tirado E
Molecular Therapy 2022; 30: 855-867
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Koller A; Brunner SM
Current Eye Research 2022; 0: 1-7
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Trost A
Biomolecules 2022; 12:
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Burri R
Molecular Therapy 2022; 30: 855-867
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Reitsamer HA
Biomolecules 2022; 12:
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Frauenknecht T
Molecular Therapy 2022; 30: 855-867
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Runge C
Current Eye Research 2022; 0: 1-7
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Hutter-Paier B
Biomolecules 2022; 12:
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Gerard MA
Molecular Therapy 2022; 30: 855-867
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Ladek AM
Current Eye Research 2022; 0: 1-7
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Salat M
Molecular Therapy 2022; 30: 855-867
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Rivera FJ
Current Eye Research 2022; 0: 1-7
99229 Leukotriene Signaling as a Target in α-Synucleinopathies
Aigner L
Biomolecules 2022; 12:
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Allenspach R
Molecular Therapy 2022; 30: 855-867
98314 Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER for Pericyte Labeling in the Retina
Reitsamer HA; Trost A
Current Eye Research 2022; 0: 1-7
98223 Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A
Agca C; Wu Z; Trost A; Bogner B; Meyer P; Scholl HPN; Reitsamer H; Flammer J; Neutzner A
Molecular Therapy 2022; 30: 855-867